|
Value in T2 ≤ T1
|
---|
Score
|
SUVmax
|
SUVmax_LN
|
SUVmean
|
SUVmean_LN
|
PSMA-TV
|
TL-PSMA
|
TL-PSMA-LN
|
---|
Prostatic lesions [n = 24]
|
23/24
|
20/24
|
19/24
|
19/24
|
17/24
|
23/24
|
22/24
|
22/24
|
Lymphonodal lesions [n = 56]
|
53/56
|
49/56
|
50/56
|
48/56
|
50/56
|
55/56
|
55/56
|
55/56
|
Bone lesions [n = 29]a
|
27/29
|
25/29
|
25/29
|
25/29
|
26/29
|
23/29
|
25/29
|
26/29
|
All lesions [n = 109]
|
103/109
|
94/109
|
94/109
|
92/109
|
93/109
|
101/109
|
102/109
|
103/109
|
- All differences are significant with a p < 0.01
- LN: liver normalization [value divided by hepatic SUVmean]
- aTwo bone metastases newly occurred at T2, and thus, higher values are seen at T2 in all surrogate parameters